Your browser doesn't support javascript.
loading
Cost and resource utilization in cervical cancer management: a real-world retrospective cost analysis.
Cromwell, I; Ferreira, Z; Smith, L; van der Hoek, K; Ogilvie, G; Coldman, A; Peacock, S J.
Afiliación
  • Cromwell I; Canadian Centre for Applied Research in Cancer Control, Vancouver, BC;; Department of Cancer Control Research, BC Cancer Agency, Vancouver, BC;
  • Ferreira Z; Canadian Centre for Applied Research in Cancer Control, Vancouver, BC;; Department of Cancer Control Research, BC Cancer Agency, Vancouver, BC;
  • Smith L; Department of Cancer Control Research, BC Cancer Agency, Vancouver, BC;
  • van der Hoek K; Canadian Centre for Applied Research in Cancer Control, Vancouver, BC;; Department of Cancer Control Research, BC Cancer Agency, Vancouver, BC;
  • Ogilvie G; School of Population and Public Health, University of British Columbia, Vancouver, BC;
  • Coldman A; Department of Cancer Control Research, BC Cancer Agency, Vancouver, BC;
  • Peacock SJ; Canadian Centre for Applied Research in Cancer Control, Vancouver, BC;; Department of Cancer Control Research, BC Cancer Agency, Vancouver, BC;; Faculty of Health Sciences, Simon Fraser University, Vancouver, BC.
Curr Oncol ; 23(Suppl 1): S14-22, 2016 Feb.
Article en En | MEDLINE | ID: mdl-26985142
ABSTRACT

OBJECTIVES:

We set out to assess the health care resource utilization and cost of cervical cancer from the perspective of a single-payer health care system.

METHODS:

Retrospective observational data for women diagnosed with cervical cancer in British Columbia between 2004 and 2009 were analyzed to calculate patient-level resource utilization patterns from diagnosis to death or 5-year discharge. Domains of resource use within the scope of this cost analysis were chemotherapy, radiotherapy, and brachytherapy administered by the BC Cancer Agency; resource utilization related to hospitalization and outpatient visits as recorded by the B.C. Ministry of Health; medically required services billed under the B.C. Medical Services Plan; and prescriptions dispensed under British Columbia's health insurance programs. Unit costs were applied to radiotherapy and brachytherapy, producing per-patient costs.

RESULTS:

The mean cost per case of treating cervical cancer in British Columbia was $19,153 (standard error $3,484). Inpatient hospitalizations, at 35%, represented the largest proportion of the total cost (95% confidence interval 32.9% to 36.9%). Costs were compared for subgroups of the total cohort.

CONCLUSIONS:

As health care systems change the way they manage, screen for, and prevent cervical cancer, cost-effectiveness evaluations of the overall approach will require up-to-date data for resource utilization and costs. We provide information suitable for such a purpose and also identify factors that influence costs.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Health_economic_evaluation / Prognostic_studies Idioma: En Revista: Curr Oncol Año: 2016 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Health_economic_evaluation / Prognostic_studies Idioma: En Revista: Curr Oncol Año: 2016 Tipo del documento: Article